These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

455 related articles for article (PubMed ID: 25747976)

  • 1. Rebamipide attenuates 5-Fluorouracil-induced small intestinal mucositis in a mouse model.
    Kim HJ; Kim JH; Moon W; Park J; Park SJ; Song GA; Han SH; Lee JH
    Biol Pharm Bull; 2015; 38(2):179-83. PubMed ID: 25747976
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Minocycline attenuates 5-fluorouracil-induced small intestinal mucositis in mouse model.
    Huang TY; Chu HC; Lin YL; Ho WH; Hou HS; Chao YC; Liao CL
    Biochem Biophys Res Commun; 2009 Nov; 389(4):634-9. PubMed ID: 19765544
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interleukin-1 receptor antagonist reduced apoptosis and attenuated intestinal mucositis in a 5-fluorouracil chemotherapy model in mice.
    Wu ZQ; Han XD; Wang Y; Yuan KL; Jin ZM; Di JZ; Yan J; Pan Y; Zhang P; Huang XY; Wang ZG; Zheng Q
    Cancer Chemother Pharmacol; 2011 Jul; 68(1):87-96. PubMed ID: 20844880
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protective effect of Bu-Zhong-Yi-Qi decoction, the water extract of Chinese traditional herbal medicine, on 5-fluorouracil-induced intestinal mucositis in mice.
    Gou H; Gu LY; Shang BZ; Xiong Y; Wang C
    Hum Exp Toxicol; 2016 Dec; 35(12):1243-1251. PubMed ID: 26801985
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oral Administration of Polaprezinc Attenuates Fluorouracil-induced Intestinal Mucositis in a Mouse Model.
    Liu Z; Xie W; Li M; Teng N; Liang X; Zhang Z; Yang Z; Wang X
    Basic Clin Pharmacol Toxicol; 2017 Dec; 121(6):480-486. PubMed ID: 28667794
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oral administration of cystine and theanine attenuates 5-fluorouracil-induced intestinal mucositis and diarrhea by suppressing both glutathione level decrease and ROS production in the small intestine of mucositis mouse model.
    Yoneda J; Nishikawa S; Kurihara S
    BMC Cancer; 2021 Dec; 21(1):1343. PubMed ID: 34922485
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lafutidine, a histamine H2 receptor antagonist with mucosal protective properties, attenuates 5-fluorouracil-induced intestinal mucositis in mice through activation of extrinsic primary afferent neurons.
    Sano T; Utsumi D; Amagase K; Matsumoto K; Tominaga M; Higuchi K; Takeuchi T; Kato S
    J Physiol Pharmacol; 2017 Feb; 68(1):79-90. PubMed ID: 28456772
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dipeptidyl-peptidase-4 (DPP-4) inhibitor ameliorates 5-flurouracil induced intestinal mucositis.
    Lee JM; Yoo IK; Lee JM; Kim SH; Choi HS; Kim ES; Keum B; Seo YS; Jeen YT; Chun HJ; Lee HS; Um SH; Kim CD
    BMC Cancer; 2019 Oct; 19(1):1016. PubMed ID: 31664952
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interleukin 1 receptor antagonist reduces lethality and intestinal toxicity of 5-fluorouracil in a mouse mucositis model.
    Wu Z; Han X; Qin S; Zheng Q; Wang Z; Xiang D; Zhang J; Lu H; Wu M; Zhu S; Yu Y; Wang Y; Han W
    Biomed Pharmacother; 2010 Nov; 64(9):589-93. PubMed ID: 20888173
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Saireito (TJ-114), a Japanese traditional herbal medicine, reduces 5-fluorouracil-induced intestinal mucositis in mice by inhibiting cytokine-mediated apoptosis in intestinal crypt cells.
    Kato S; Hayashi S; Kitahara Y; Nagasawa K; Aono H; Shibata J; Utsumi D; Amagase K; Kadowaki M
    PLoS One; 2015; 10(1):e0116213. PubMed ID: 25565296
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alleviation of 5-fluorouracil-induced intestinal mucositis in rats by vitamin E via targeting oxidative stress and inflammatory markers.
    Al-Asmari AK; Khan AQ; Al-Asmari SA; Al-Rawi A; Al-Omani S
    J Complement Integr Med; 2016 Dec; 13(4):377-385. PubMed ID: 27682716
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mucoprotective effects of Saikosaponin-A in 5-fluorouracil-induced intestinal mucositis in mice model.
    Ali J; Khan AU; Shah FA; Ali H; Islam SU; Kim YS; Khan S
    Life Sci; 2019 Dec; 239():116888. PubMed ID: 31639401
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Apoptosis, Dysbiosis and Expression of Inflammatory Cytokines are Sequential Events in the Development of 5-Fluorouracil-Induced Intestinal Mucositis in Mice.
    Hamouda N; Sano T; Oikawa Y; Ozaki T; Shimakawa M; Matsumoto K; Amagase K; Higuchi K; Kato S
    Basic Clin Pharmacol Toxicol; 2017 Sep; 121(3):159-168. PubMed ID: 28374966
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Probiotic Bifidobacterium bifidum G9-1 attenuates 5-fluorouracil-induced intestinal mucositis in mice via suppression of dysbiosis-related secondary inflammatory responses.
    Kato S; Hamouda N; Kano Y; Oikawa Y; Tanaka Y; Matsumoto K; Amagase K; Shimakawa M
    Clin Exp Pharmacol Physiol; 2017 Oct; 44(10):1017-1025. PubMed ID: 28590519
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rebamipide has the potential to reduce the intensity of NSAID-induced small intestinal injury: a double-blind, randomized, controlled trial evaluated by capsule endoscopy.
    Fujimori S; Takahashi Y; Gudis K; Seo T; Ehara A; Kobayashi T; Mitsui K; Yonezawa M; Tanaka S; Tatsuguchi A; Sakamoto C
    J Gastroenterol; 2011 Jan; 46(1):57-64. PubMed ID: 20924615
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of platelet-activating factor in the pathogenesis of 5-fluorouracil-induced intestinal mucositis in mice.
    Soares PM; Lima-Junior RC; Mota JM; Justino PF; Brito GA; Ribeiro RA; Cunha FQ; Souza MH
    Cancer Chemother Pharmacol; 2011 Sep; 68(3):713-20. PubMed ID: 21153821
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rebamipide inhibits indomethacin-induced small intestinal injury: possible involvement of intestinal microbiota modulation by upregulation of α-defensin 5.
    Tanigawa T; Watanabe T; Otani K; Nadatani Y; Ohkawa F; Sogawa M; Yamagami H; Shiba M; Watanabe K; Tominaga K; Fujiwara Y; Takeuchi K; Arakawa T
    Eur J Pharmacol; 2013 Mar; 704(1-3):64-9. PubMed ID: 23428631
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lyprinol only partially improves indicators of small intestinal integrity in a rat model of 5-fluorouracil-induced mucositis.
    Torres DM; Tooley KL; Butler RN; Smith CL; Geier MS; Howarth GS
    Cancer Biol Ther; 2008 Feb; 7(2):295-302. PubMed ID: 18059190
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interleukin 1 receptor antagonist reduces lethality and intestinal toxicity of 5-Fluorouracil in a mouse mucositis model.
    Wu Z; Han X; Qin S; Zheng Q; Wang Z; Xiang D; Zhang J; Lu H; Wu M; Zhu S; Yu Y; Wang Y; Han W
    Biomed Pharmacother; 2011 Aug; 65(5):339-44. PubMed ID: 21723691
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protective effect of rebamipide against celecoxib-induced gastric mucosal cell apoptosis.
    Ishihara T; Tanaka K; Tashiro S; Yoshida K; Mizushima T
    Biochem Pharmacol; 2010 Jun; 79(11):1622-33. PubMed ID: 20132796
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.